Dynavax Technologies Corp reports results for the quarter ended June 30 - Earnings Summary

• Dynavax Technologies Corp DVAX.OQ reported quarterly adjusted earnings of 14 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 8 cents. The mean expectation of five analysts for the quarter was for earnings of 11 cents per share. Wall Street expected results to range from 5 cents to 14 cents per share.

• Revenue rose 29.3% to $95.44 million from a year ago; analysts expected $86.66 million.

• Dynavax Technologies Corp's reported EPS for the quarter was 14 cents​.

• The company reported quarterly net income of $18.72 million.

• Dynavax Technologies Corp shares had risen by 12.8% this quarter and lost 12.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 9.7% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Dynavax Technologies Corp is $25.00, about 55.8% above its last closing price of $11.06

This summary was machine generated from LSEG data August 8 at 03:20 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)